You are here: Industry Insights > Market News > China's Sinopharm COVID-19 vaccines arrive in Thailand

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

Gelatin, Soft Capsule Gelatin, Hard Capsule Gelatin, Pharmaceutical Gelatin-Foodmate

Neohesperidin

Advantame

Cleanroom Bench Horizontal Laminar Flow Hood Airflow Clean Bench

Pharma and Food Grade, USP/FCC Neotame Sweetener E961

Trilobatin

China's Sinopharm COVID-19 vaccines arrive in Thailand

firstwordpharmaJune 21, 2021

Tag: Sinopharm , COVID-19 , vaccines

Favorites

A batch of Sinopharm COVID-19 vaccines landed in Bangkok on Sunday, as reported China Daily.

China's Sinopharm COVID-19 vaccines arrive in Thailand

The Chulabhorn Royal Academy announced that 17,070 organisations and companies nationwide had registered to obtain the Sinopharm vaccine to inoculate their employees.

The country approved the vaccine for emergency use in May, following the approvals of AstraZeneca, Sinovac, Johnson & Johnson and Moderna vaccines.

Thailand aims to vaccinate about 70% of its nearly 70 million population by the end of the year.

Previous:Cuba encouraged by early trials of homegrown COVID-19 vaccine

Next:Urgently trying to work with AstraZeneca, SII, Indian govt to resume shipments of COVID-19 vaccines: WHO

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Everest Medicines LimitedDecember 20, 2024

Everest Medicines announced NMPA acceptance of NDA for VELSIPITY(R) (etrasimod) to treat moderately to severely active UC.

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

PRNewswireDecember 12, 2024

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

PRNewswireDecember 12, 2024

China's Sinopharm COVID-19 vaccines arrive in Thailand | Pharmasources.com

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

PRNewswireDecember 12, 2024

Core8 Group, an Australian leader in high-tech and biotech innovation, has unveiled plans to develop Vietnam's first AI x ESG Hospital, marking a significant milestone in healthcare transformation.

China's Sinopharm COVID-19 vaccines arrive in Thailand

Related News

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

You may like
More>>

China's Sinopharm COVID-19 vaccines arrive in Thailand

Related News

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

You may likeMore>>

You may like
More>>